Clarivate Enhances OFF-X with Pathway Maps to Accelerate Target Safety Assessments - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) # Clarivate Enhances OFF-X with Pathway Maps to Accelerate Target Safety Assessments ##### Up next ###### [Progress closing the mobile internet gender gap stalls in LMICs: GSMA Mobile Gender Gap Report 2025](https://thailandbusinessnews.net/press-release/progress-closing-the-mobile-internet-gender-gap-stalls-in-lmics-gsma-mobile-gender-gap-report-2025/) Published on 14 May 2025 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) ![](https://mma.prnasia.com/media2/1159266/Clarivate_Logo_v1.jpg?p=medium600 "logo") R&D teams can streamline safety evaluations, reduce risks and enable faster decision-making in drug development using new visual and data-driven insights LONDON, May 14, 2025 /PRNewswire/ — [Clarivate Plc](https://c212.net/c/link/?t=0&l=en&o=4417877-1&h=275300479&u=https%3A%2F%2Fclarivate.com%2F&a=Clarivate+Plc) (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the incorporation of [Pathway Maps in OFF-X](https://c212.net/c/link/?t=0&l=en&o=4417877-1&h=1851977880&u=https%3A%2F%2Fclarivate.com%2Flife-sciences-healthcare%2Fresearch-development%2Fpharmacovigilance-drug-safety%2Foff-x%2F%3Fcampaignname%3DOFFX_PR_Pathway_Maps_Announcement_LeadGen_LS_Global_2025%26campaignid%3D701VO00000Xi4MnYAJ%26utm_campaign%3DOFFX-Pathway-Maps-PR-Release%26utm_sou&a=Pathway+Maps+in+OFF-X), a cutting-edge translational safety intelligence solution. With over 30% of drug development failures attributed to safety issues1, preclinical and translational research teams face increasing pressure to identify potential liabilities earlier in the target selection process. Pathway Maps provide powerful visual tools that offer deeper insights into the biological mechanisms underlying diseases and target interactions, streamlining target safety assessments and enabling faster, data-driven decisions. Traditional safety data collection is often fragmented and time-consuming, creating delays in critical go/no-go decisions. With the addition of Pathway Maps to OFF-X, researchers can now explore disease-specific visualizations of key signaling pathways and molecular processes—uniquely overlaid with curated, multi-source safety data. This integration enables users to quickly pinpoint potential safety liabilities across upstream or downstream targets, adding biological context to risk assessment. By bringing together visual disease biology and comprehensive safety intelligence in one platform, OFF-X addresses a critical industry gap—empowering teams to make faster, more confident decisions across the drug development lifecycle. Anne Lecocq, SVP and GM, R&D, Life Sciences & Healthcare, Clarivate, said: "The ability to assess the safety of drug targets early in development is a critical factor in reducing costly late-stage failures and accelerating time to market. At Clarivate, we’re committed to empowering our customers with tools that not only streamline their workflows but also provide deeper, more actionable insights that improve patient lives and create a healthier tomorrow. The introduction of Pathway Maps into OFF-X is a game-changer—it integrates complex biological data with curated safety intelligence, helping researchers make confident, data-driven decisions faster and with greater accuracy." With this release, OFF-X reaffirms its unique position as a platform that integrates proprietary physiological and disease pathway visualizations with curated safety data from diverse sources. This integration streamlines data access and enhances risk evaluation, providing researchers with the confidence to make more informed decisions and refine mitigation strategies. Designed to support researchers throughout the drug development lifecycle—from early discovery to post-marketing surveillance— OFF-X offers a unified resource for translational safety intelligence. In the drug discovery and preclinical space, the combination OFF-X and Cortellis Drug Discovery Intelligence provides the most powerful approach for researchers to cover both efficacy and safety. For more information on how OFF-X helps optimize target safety assessments, visit [here.](https://c212.net/c/link/?t=0&l=en&o=4417877-1&h=841038859&u=https%3A%2F%2Fclarivate.com%2Flife-sciences-healthcare%2Fresearch-development%2Fpharmacovigilance-drug-safety%2Foff-x%2F%3Fcampaignname%3DOFFX_PR_Pathway_Maps_Announcement_LeadGen_LS_Global_2025%26campaignid%3D701VO00000Xi4MnYAJ%26utm_campaign%3DOFFX-Pathway-Maps-PR-Release%26utm_source%3DPress_Release%26utm_medium%3DPaid_Press%26utm_content%3D%26utm_term%3DOFF-X&a=here.) About Clarivate Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit [clarivate.com](https://c212.net/c/link/?t=0&l=en&o=4417877-1&h=1517527444&u=https%3A%2F%2Fclarivate.com%2Fnewsroom%2F&a=clarivate.com) 1 Source: Guengerich FP. [Mechanisms of drug toxicity and relevance to pharmaceutical development.](https://c212.net/c/link/?t=0&l=en&o=4417877-1&h=2668837239&u=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F20978361%2F&a=Mechanisms+of+drug+toxicity+and+relevance+to+pharmaceutical+development.) Drug Metab Pharmacokinet. 2011;26(1):3-14. doi: 10.2133/dmpk.dmpk-10-rv-062. Epub October 22, 2010. PMID: 20978361; PMCID: PMC4707670. Media Contact: Catherine DanielDirector, External Communications, Life Sciences & HealthcareClarivate [Source link ](https://www.prnasia.com/story/archive/4677724_AE77724_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/sustainable-markets-initiative-announces-2023-terra-carta-seal-winners/) ![Sustainable Markets Initiative Announces 2023 Terra Carta Seal Winners](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2023/10/SSampC-Completes-Acquisition-of-Iress039-Managed-Funds-Administration-Business.jpg?resize=260%2C140&ssl=1 "Sustainable Markets Initiative Announces 2023 Terra Carta Seal Winners") - [Banking](https://thailandbusinessnews.net/category/banking/) - [Business](https://thailandbusinessnews.net/category/business/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## Sustainable Markets Initiative Announces 2023 Terra Carta Seal Winners 17 global companies have been awarded the Sustainable Markets Initiative’s 2023 Terra… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - November 28, 2023 [](https://thailandbusinessnews.net/press-release/sk-hynix-reports-financial-results-for-2023-4q23/) ![SK hynix Reports Financial Results for 2023, 4Q23](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2023/10/SSampC-Completes-Acquisition-of-Iress039-Managed-Funds-Administration-Business.jpg?resize=260%2C140&ssl=1 "SK hynix Reports Financial Results for 2023, 4Q23") - [Business](https://thailandbusinessnews.net/category/business/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) - [Tech](https://thailandbusinessnews.net/category/tech/) ## SK hynix Reports Financial Results for 2023, 4Q23 – Reports first quarterly profit in a year, backed by demand recovery,… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - January 25, 2024 [](https://thailandbusinessnews.net/press-release/bingx-charity-donates-over-1-billion-vnd-to-support-flood-affected-communities-in-central-and-northern-vietnam/) ![BingX Charity Donates Over 1 Billion VND to Support Flood-Affected Communities in Central and Northern Vietnam](https://i0.wp.com/thailandbusinessnews.net/wp-content/uploads/2025/07/BingX_logo_Logo.jpg?resize=260%2C140&ssl=1 "BingX Charity Donates Over 1 Billion VND to Support Flood-Affected Communities in Central and Northern Vietnam") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## BingX Charity Donates Over 1 Billion VND to Support Flood-Affected Communities in Central and Northern Vietnam PANAMA CITY, Oct. 24, 2025 /PRNewswire/ — BingX Charity, the philanthropic arm… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - October 24, 2025 ##### Most Read - [![DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dbs-hong-kong-partners-with-visa-preface-to-empower-customers-with-ai-readiness-skills-for-the-future-of-intelligent-payments/ "DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments") [DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments](https://thailandbusinessnews.net/press-release/dbs-hong-kong-partners-with-visa-preface-to-empower-customers-with-ai-readiness-skills-for-the-future-of-intelligent-payments/ "DBS Hong Kong Partners with Visa, Preface to empower Customers with AI Readiness skills, for the Future of Intelligent Payments") - [![Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/piramal-pharma-limited-completes-acquisition-of-controlling-stake-in-yapan-bio-private-limited/ "Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited") [Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited](https://thailandbusinessnews.net/press-release/piramal-pharma-limited-completes-acquisition-of-controlling-stake-in-yapan-bio-private-limited/ "Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited") - [![ZTO Reports Second Quarter 2026 Unaudited Financial Results](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/zto-reports-second-quarter-2026-unaudited-financial-results/ "ZTO Reports Second Quarter 2026 Unaudited Financial Results") [ZTO Reports Second Quarter 2026 Unaudited Financial Results](https://thailandbusinessnews.net/press-release/zto-reports-second-quarter-2026-unaudited-financial-results/ "ZTO Reports Second Quarter 2026 Unaudited Financial Results") - [![GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/gsks-blenrep-belantamab-mafodotin-combinations-approved-in-singapore-for-treatment-of-relapsed-refractory-multiple-myeloma/ "GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma") [GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma](https://thailandbusinessnews.net/press-release/gsks-blenrep-belantamab-mafodotin-combinations-approved-in-singapore-for-treatment-of-relapsed-refractory-multiple-myeloma/ "GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma") - [![Everest Medicines Announces Interim Results for First Half of 2026](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/everest-medicines-announces-interim-results-for-first-half-of-2026/ "Everest Medicines Announces Interim Results for First Half of 2026") [Everest Medicines Announces Interim Results for First Half of 2026](https://thailandbusinessnews.net/press-release/everest-medicines-announces-interim-results-for-first-half-of-2026/ "Everest Medicines Announces Interim Results for First Half of 2026") - [![Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/taiwantrade-com-brings-taiwans-ict-excellence-to-computex-2025/ "Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025") [Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025](https://thailandbusinessnews.net/press-release/taiwantrade-com-brings-taiwans-ict-excellence-to-computex-2025/ "Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/autohome-inc-announces-unaudited-second-quarter-and-interim-2026-financial-results/) ## Autohome Inc. Announces Unaudited Second Quarter and Interim 2026 Financial Results BEIJING, Aug. 20, 2026 /PRNewswire/ — Autohome Inc. (NYSE: ATHM; HKEX: 2518)… [](https://thailandbusinessnews.net/press-release/jt-express-adjusted-net-profit-up-124-3-yoy-in-1h2026-overall-profitability-continues-to-strengthen/) ## J&T Express Adjusted Net Profit Up 124.3% YoY in 1H2026; Overall Profitability Continues to Strengthen Southeast Asia Leading Position Sustained; Market Share in China and Other Markets… [](https://thailandbusinessnews.net/press-release/agoda-reveals-europes-2026-summer-travel-interest-to-asia-thailand-leads-indonesia-rises-to-second-and-vietnam-climbs/) ## Agoda Reveals Europe's 2026 Summer Travel Interest to Asia: Thailand Leads, Indonesia Rises to Second and Vietnam Climbs SINGAPORE, Aug. 20, 2026 /PRNewswire/ — Digital travel platform Agoda has… [](https://thailandbusinessnews.net/press-release/iherb-kicks-off-30th-anniversary-celebrations-in-hong-kong/) ![iHerb Kicks Off 30th Anniversary Celebrations in Hong Kong](https://i0.wp.com/mmx.prnasia.com/media/MS1972895/20260820022729EDT_image_1.jpg?resize=260%2C140&ssl=1 "iHerb Kicks Off 30th Anniversary Celebrations in Hong Kong") ## iHerb Kicks Off 30th Anniversary Celebrations in Hong Kong HONG KONG, Aug. 20, 2026 /PRNewswire/ — Ahead of its 30th anniversary, iHerb…